DISCOUNT ZERTIFIKAT - STRYKER CORP. Stock

Certificat

DE000PC4H510

Market Closed - Boerse Frankfurt Warrants 15:40:19 2024-05-24 EDT
252.6 EUR -0.24% Intraday chart for DISCOUNT ZERTIFIKAT - STRYKER CORP.
Current month-0.83%
1 month-0.50%
Date Price Change
24-05-24 252.6 -0.24%
24-05-23 253.3 +0.04%
24-05-22 253.2 +0.40%
24-05-21 252.2 +0.10%
24-05-20 251.9 +0.11%

Real-time Boerse Frankfurt Warrants

Last update May 24, 2024 at 03:40 pm

More quotes

Static data

Product typeDiscount Certificates
Buy / SellCALL
Underlying STRYKER CORPORATION
IssuerLogo Issuer BNP Paribas BNP Paribas
WKN PC4H51
ISINDE000PC4H510
Date issued 2024-02-02
Maturity 2024-09-20 (119 Days)
Parity 1 : 1
Emission price 242.6
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 255.5
Lowest since issue 245.9
Spread 0.5
Spread %0.20%

Company Profile

Stryker Corporation is one of the world's leaders in designing, manufacturing, and selling orthopedic equipments. Net sales break down by family of products as follows: - surgical equipments and neurotechnology products (57.5%): electric motorized surgical instruments, surgical navigation systems, endoscopy equipment, digital imaging systems, neurosurgery equipments, neurovascular devices, etc. The group also offers hospital beds, gurneys, stretchers, and emergency room equipment; - orthopedic implants (42.5%): joint prostheses, traumatology implants, micro-implants, orthopedic cement, orthobiology products, etc. The group also provides spinal implants. At the end of 2022, the group had 48 production sites worldwide. Net sales are distributed geographically as follows: the United States (73.9%), Europe/Middle East/Africa (12.7%), Asia/Pacific (10.2%) and other (3.2%).
Sector
-
More about the company

Ratings for Stryker Corporation

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings

Consensus: Stryker Corporation

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
29
Last Close Price
335.5 USD
Average target price
372.4 USD
Spread / Average Target
+10.97%
Consensus